Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$10.32 - $12.13 $463,925 - $545,292
44,954 Added 3.39%
1,372,670 $15.9 Million
Q2 2024

Jul 29, 2024

SELL
$10.05 - $12.02 $450,008 - $538,219
-44,777 Reduced 3.26%
1,327,716 $14.1 Million
Q1 2024

Apr 29, 2024

BUY
$11.27 - $13.53 $227,687 - $273,346
20,203 Added 1.49%
1,372,493 $16.4 Million
Q4 2023

Feb 07, 2024

SELL
$8.77 - $10.85 $335,206 - $414,708
-38,222 Reduced 2.75%
1,352,290 $14.6 Million
Q3 2023

Nov 02, 2023

SELL
$9.59 - $11.35 $798,674 - $945,250
-83,282 Reduced 5.65%
1,390,512 $13.7 Million
Q2 2023

Aug 07, 2023

SELL
$9.02 - $10.29 $383,981 - $438,045
-42,570 Reduced 2.81%
1,473,794 $14.7 Million
Q1 2023

May 09, 2023

BUY
$9.2 - $12.26 $67,813 - $90,368
7,371 Added 0.49%
1,516,364 $14.6 Million
Q4 2022

Feb 09, 2023

SELL
$8.72 - $11.56 $2.05 Million - $2.71 Million
-234,707 Reduced 13.46%
1,508,993 $16.8 Million
Q3 2022

Nov 09, 2022

SELL
$8.48 - $11.13 $1.11 Million - $1.45 Million
-130,622 Reduced 6.97%
1,743,700 $14.9 Million
Q2 2022

Aug 10, 2022

BUY
$9.95 - $12.27 $2.44 Million - $3.01 Million
245,290 Added 15.06%
1,874,322 $19.6 Million
Q1 2022

May 09, 2022

BUY
$9.81 - $15.4 $158,058 - $248,124
16,112 Added 1.0%
1,629,032 $17.7 Million
Q4 2021

Feb 09, 2022

BUY
$12.09 - $14.68 $1.14 Million - $1.38 Million
94,129 Added 6.2%
1,612,920 $21.8 Million
Q3 2021

Nov 09, 2021

BUY
$13.25 - $15.13 $248,808 - $284,111
18,778 Added 1.25%
1,518,791 $20.6 Million
Q2 2021

Aug 10, 2021

BUY
$12.97 - $16.15 $30,972 - $38,566
2,388 Added 0.16%
1,500,013 $21.4 Million
Q1 2021

May 10, 2021

SELL
$13.59 - $18.54 $1.18 Million - $1.6 Million
-86,517 Reduced 5.46%
1,497,625 $20.9 Million
Q4 2020

Feb 08, 2021

BUY
$14.3 - $18.74 $22.7 Million - $29.7 Million
1,584,142 New
1,584,142 $29.7 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.